Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Saccharomyces cerevisiae

ABSTRACT: Lab-evolved S. cerevisiae populations

PROVIDER: PRJNA380825 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR5406210.fastq.gz	Fastqsanger.gz
	SRR5406220.fastq.gz	Fastqsanger.gz
	SRR5406230.fastq.gz	Fastqsanger.gz
	SRR5406240.fastq.gz	Fastqsanger.gz
	SRR5406250.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 1365

Similar Datasets

CGH of natural Saccharomyces cerevisiae strains

Project description:Comparative Genomic Hybridization of natural Saccharomyces cerevisiae strains vs lab reference strains.

2020-12-31 | GSE136466 | GEO

Project description:Lab-evolved S. cerevisiae populations

| PRJNA516029 | ENA

Saccharomyces cerevisiae

Project description:Flocculating evolved strains of S. cerevisiae

| PRJNA339148 | ENA

Saccharomyces cerevisiae S288C

Project description:Experimentally-evolved Saccharomyces cerevisiae clones

| PRJNA784975 | ENA

Saccharomyces cerevisiae S288C

Project description:Saccaromyces cerevisiae CoSMO evolved isolates

| PRJNA196442 | ENA

Ecological success of a group of Saccharomyces cerevisiae / Saccharomyces kudriavzevii hybrids in the Northern European wine making environment.

Project description:The aim of this project was to evaluate the ploidy of a S. cerevisiae *S. kudriavzevii hybrid in comparison to the lab strain S288C. Other wine yeast have been icluded in the project for the global analysis.

2012-02-09 | GSE31703 | GEO

Saccharomyces cerevisiae

Project description:Genome sequence project of laboratory evolved Saccharomyces cerevisiae strains

| PRJDB4375 | ENA

Expression data of antibody fragments from Saccharomyces cerevisiae

Project description:Saccharomyces cerevisiae has been used as a secretion host for production of various products, including pharmaceuticals. However, few antibody molecules have been functionally expressed in S. cerevisiae due to the incompatible surface glycosylation. Our laboratory previously isolated a group of yeast mutant strains with different α-amylase secretory capacities, and these evolved strains have showed advantages for production of some heterologous proteins. However, it is not known whether these secretory strains are generally suitable for pharmaceutical protein production. Here, three non-glycosylated antibody fragments with different configurations (Ran-Fab fragment Ranibizumab, Pex-the scFv peptide Pexelizumab, and Nan-a single V-type domain) were successfully expressed and secreted in three background strains with different secretory capacities, including HA (wild type), MA (evolved strain), and LA (evolved strain). However, the secretion of Ran and Nan were positively correlated with the strains’ secretory capacity, while Pex was most efficiently secreted in the parental strain. Therefore, transcriptional analysis was performed to explore the fundamental changes triggered by the expression of the different pharmaceutical proteins in these selected yeast strains.

2021-07-06 | GSE179391 | GEO

Transcriptome analysis of arabinose fermentation by engineered Saccharomyces cerevisiae

Project description:Saccharomyces cerevisiae IMS0002 which, after metabolic and evolutionary engineering, ferments the pentose sugar arabinose. Glucose and arabinose-limited anaerobic chemostat cultures of IMS0002 and its non-evolved ancestor IMS0001 were subjected to transcriptome analysis to identify key genetic changes contributing to efficient arabinose utilization by strain IMS0002.

2011-03-01 | GSE27539 | GEO

Saccharomyces cerevisiae

Project description:High-throughput identification of adaptive mutations in experimentally evolved yeast populations

| PRJNA252936 | ENA